Clinical Trials for Advanced Non-squamous Non-small-cell Lung Cancer

Find clinical trials for advanced non-squamous non-small-cell lung cancer. Discover research opportunities and treatment options in your area.

4 Active Trials Found

Showing 4 trials on this page

Page 1 of 1

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

NCT ID: NCT06463665

This clinical trial is exploring a new treatment approach for patients with advanced or metastatic non-small cell lung cancer (NSCLC), a type of lung cancer that has spread and is harder to treat. ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Miami, Florida, United States, Plantation, Florida, United States +8 more

A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

NCT ID: NCT06585488

This clinical trial is studying a new medication called BGB-53038, which is designed to target specific changes in cancer cells known as KRAS mutations. These changes can make certain types of canc...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seoul, , Korea, Republic Of, Houston, Texas, United States +25 more

JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation

NCT ID: NCT06416410

This clinical trial is studying a new treatment combination called JAB-21822 and JAB-3312 for patients with advanced non-small cell lung cancer (NSCLC) that has a specific mutation known as KRAS p....

Recruiting

Phase: PHASE3 Type: interventional Locations: Nanjing, Jiangsu, China, Wuxi, Jiangsu, China +36 more

Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients

NCT ID: NCT06028633

This clinical trial is studying a new combination of treatments for patients with advanced non-small-cell lung cancer (NSCLC) who have not responded to previous chemotherapy. The treatment being te...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions